Position in IXHL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$10,580
-$71,881 QoQ
Shares Held
2,814
-52.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 15 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IXHL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. IXHL ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
262,200 | $142,067,824 | |
| 2 | ZTS |
Zoetis Inc.
|
1,265,210 | $90,917,989 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,527,031 | $85,615,809 | |
| 4 | VTRS |
Viatris Inc
|
4,360,444 | $69,243,850 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
179,076 | $30,181,467 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
643,006 | $26,382,535 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
189,692 | $21,044,429 | |
| 8 | HLN |
Haleon plc
|
1,507,538 | $14,065,329 |
All Filings in IXHL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,580 | 2,814 | Shares | Defined | 2026-08-03 | |
| 2025-09-30 | $82,461 | 177,718 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $5,718 | 26,474 | Shares | Defined | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||